Ip3: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
mNo edit summary |
||
| Line 1: | Line 1: | ||
[[IP3]] ([[Inositol 1,4,5-trisphosphate|Inositol 1,4,5-trisphosphate]]) is a cleavage product of [[ | [[IP3]] ([[Inositol 1,4,5-trisphosphate|Inositol 1,4,5-trisphosphate]]) is a cleavage product of [[Phosphatidylinositol 4,5-bisphosphate|phosphatidylinositol 4,5-bisphosphate]] ([[Phosphatidylinositol 4,5-bisphosphate|PIP]]<sub>[[Phosphatidylinositol 4,5-bisphosphate|2]]</sub>). [[Phosphatidylinositol 4,5-bisphosphate|PIP]]<sub>[[Phosphatidylinositol 4,5-bisphosphate|2]]</sub> is a [[Phospholipid|phospholipid]] molecule cleaved into inositol 1,4,5-trisphosphate and [[Diacylglycerol|diacylglycerol]] ([[Diacylglycerol|DAG]]) by phospholipase C after hormone binding to the receptor. Inositol 1,4,5-trisphosphate binds to IP3 receptor which results to the release of calcium from the calcium pumps. | ||
Revision as of 14:35, 8 November 2010
IP3 (Inositol 1,4,5-trisphosphate) is a cleavage product of phosphatidylinositol 4,5-bisphosphate (PIP2). PIP2 is a phospholipid molecule cleaved into inositol 1,4,5-trisphosphate and diacylglycerol (DAG) by phospholipase C after hormone binding to the receptor. Inositol 1,4,5-trisphosphate binds to IP3 receptor which results to the release of calcium from the calcium pumps.